Skip to content

study on itching and swelling

CLINICO EPIDEMIOLOGICAL STUDY OF CHRONIC URTICARIA-A CROSS SECTIONAL OBSERVATIONAL STUDY.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047111
Enrollment
78
Registered
2022-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Sponsors

sushil kumar singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient of chronic urticaria presenting in the outpatient department of Dermatology.

Exclusion criteria

Exclusion criteria: Acute urticaria 2. Angioedema without urticaria 3. Patients of CSU who has taken steroids or immunosuppressive in the last four weeks 4. Urticarial syndromes like Schnitzler's syndrome etc. 5. Other causes of urticarial rashes like lesion associated with systemic lupus, mastocytosis 6. Urticarial vasculitis 7. Age below 12 years 8. Special groups such as pregnancy.

Design outcomes

Primary

MeasureTime frame
Demographic profile of patients 2. Clinical profile of the disease including disease duration 3. Disease severity at presentation measured with UAS7 scores 4. Autoreactivity determined by ASST positivity 5. Blood tests including anti-TPO antibodies, ANA (hep 2), IgE, and rheumatoid factor to find out possible association with autoimmune disease.Timepoint: 18 months

Secondary

MeasureTime frame
To find out the proportion of autoreactive cases amongst the patients of CU by ASST 2. To find out the presence of autoantibodies like rheumatoid factor, ANA (Hep2), and anti-TPO antibodies 3. To find out disease association of CU with other autoimmune or allergic diseases 4. To find out the presence of physical inducibility in patients of CU 5. To correlate disease severity (by UAS7 score) and disease duration with the presence of signs of autoimmunity (presence of autoantibodies and ASST positivity)Timepoint: 18 months

Countries

India

Contacts

Public ContactSUSHIL KUMAR SINGH

calcutta national medical college

dr_abhishek_de@yahoo.co.in07972511782

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026